Bazedoxifene/conjugated estrogens
Combination drug
From Wikipedia, the free encyclopedia
Bazedoxifene/conjugated estrogens, sold under the brand name Duavee among others, is a fixed-dose combination medication for the treatment of menopause symptoms and postmenopausal osteoporosis.[3][5][6] It contains the selective estrogen receptor modulator bazedoxifene and conjugated estrogens.[3] It is taken by mouth.[3]
Trade namesDuavee, Duavive
| Combination of | |
|---|---|
| Bazedoxifene | Selective estrogen receptor modulator |
| Conjugated estrogens | Estrogen |
| Clinical data | |
| Trade names | Duavee, Duavive |
| AHFS/Drugs.com | Professional Drug Facts |
| MedlinePlus | a614004 |
| License data | |
| Pregnancy category |
|
| Routes of administration | By mouth |
| ATC code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| KEGG | |
The combination was approved for medical use in the United States in October 2013,[7] and in the European Union in December 2014.[4]
